Clinical Trials Browser

Phase 2 × Nasopharyngeal Neoplasms × Oxaliplatin × Clear all

NCT00439426 2016-11-02

A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.

Phase 2 Completed

25 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT00091182 2013-06-05

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Phase 2 Completed

180 enrolled

CNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Astrocytoma, Carcinoma, Renal Cell, Colonic Neoplasms, Nasopharyngeal Neoplasms, Neuroblastoma, Rectal Neoplasms, Osteosarcoma, Teratoma, Testicular Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Adrenocortical Carcinoma, Optic Nerve Glioma

NCT00363831 2010-07-28

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

42 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT00436800 2009-09-18

Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma

Phase 2 Completed

41 enrolled

Head & Neck

Nasopharyngeal Neoplasms